These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17102561)

  • 1. How reliable are models for malaria vaccine development? Lessons from irradiated sporozoite immunizations.
    Chatterjee S; Perignon JL; Van Marck E; Druilhe P
    J Postgrad Med; 2006; 52(4):321-4. PubMed ID: 17102561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rodent malaria in the natural host--irradiated sporozoites of Plasmodium berghei induce liver-stage specific immune responses in the natural host Grammomys surdaster and protect immunized Grammomys against P. berghei sporozoite challenge.
    Chatterjee S; Ngonseu E; Van Overmeir C; Correwyn A; Druilhe P; Wéry M
    Afr J Med Med Sci; 2001; 30 Suppl():25-33. PubMed ID: 14513935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
    Good MF
    Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.
    Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH
    J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics and Outcomes of
    Conteh S; Kolasny J; Robbins YL; Pyana P; Büscher P; Musgrove J; Butler B; Lambert L; Gorres JP; Duffy PE
    Am J Trop Med Hyg; 2020 Nov; 103(5):1893-1901. PubMed ID: 32815499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of immunity to Plasmodium: implications from mouse models for blood stage malaria vaccine design.
    Taylor-Robinson AW
    Exp Parasitol; 2010 Nov; 126(3):406-14. PubMed ID: 20138874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depletion of the Plasmodium berghei thrombospondin-related sporozoite protein reveals a role in host cell entry by sporozoites.
    Labaied M; Camargo N; Kappe SH
    Mol Biochem Parasitol; 2007 Jun; 153(2):158-66. PubMed ID: 17418435
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Conteh S; Anderson C; Lambert L; Orr-Gonzalez S; Herrod J; Robbins YL; Carter D; Karhemere SBS; Pyana P; Büscher P; Duffy PE
    Am J Trop Med Hyg; 2017 Apr; 96(4):835-841. PubMed ID: 28115674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination using normal live sporozoites under drug treatment.
    Rénia L; Grüner AC; Mauduit M; Snounou G
    Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative invasion pathways for Plasmodium berghei sporozoites.
    Silvie O; Franetich JF; Boucheix C; Rubinstein E; Mazier D
    Int J Parasitol; 2007 Feb; 37(2):173-82. PubMed ID: 17112526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High road, low road? Choices and challenges on the pathway to a malaria vaccine.
    Richie T
    Parasitology; 2006; 133 Suppl():S113-44. PubMed ID: 17274843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria vaccine: a current perspective.
    Sharma S; Pathak S
    J Vector Borne Dis; 2008 Mar; 45(1):1-20. PubMed ID: 18399312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-parasite interactions for virulence and resistance in a malaria model system.
    Grech K; Watt K; Read AF
    J Evol Biol; 2006 Sep; 19(5):1620-30. PubMed ID: 16910991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-erythrocytic stage malaria vaccines: time for a change in path.
    Druilhe P; Barnwell JW
    Curr Opin Microbiol; 2007 Aug; 10(4):371-8. PubMed ID: 17709281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What have we learnt from mouse models for the study of malaria?
    Wykes MN; Good MF
    Eur J Immunol; 2009 Aug; 39(8):2004-7. PubMed ID: 19672886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
    J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A perspective on malaria vaccines.
    Desowitz RS; Miller LH
    Bull World Health Organ; 1980; 58(6):897-908. PubMed ID: 6783333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Migration through host cells: the first steps of Plasmodium sporozoites in the mammalian host.
    Mota MM; Rodriguez A
    Cell Microbiol; 2004 Dec; 6(12):1113-8. PubMed ID: 15527491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.